Topics covered:
-Understanding the biology of a disease
-First Steps: Hit to Lead and (Q)SAR
-Hit-to-Lead Validation Process, ADME and Toxicology
-Lead Development through Small and Large Animal Model Studies
-FORMULATION and DRUG DELIVERY
-Intellectual Properties and Interactions with Regulatory agencies (FDA, EMA,CFDA, etc.)
-Biologics and CRISPR
-Phase I, II, and III Clinical Trials